中生北控生物科技(08247)发盈警 预期2024年净亏损约5500万-6000万元

智通财经
20 Mar

智通财经APP讯,中生北控生物科技(08247)公布,该集团预期于2024年取得净亏损约人民币5500万-6000万元,而2023年净亏损为1924万元。

公告称,亏损净额增加乃主要由于受行业集采影响,产品价格下降导致毛利减少约人民币1900万元;报告期内计提无形资产、固定资产及投资物业减值亏损拨备约人民币1300万元,而2023年同期约为人民币60万元;及报告期内计提应收贸易账款及票据以及其他应收款减值亏损拨备约人民币650万元,而2023年同期约为人民币70万元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10